Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026)

Akebia Therapeutics (AKBA) has 9 years of Debt Ratio data on file, last reported at 0.13 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 10.06% year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.13, a 10.06% decrease from a year earlier, with the FY2025 full-year figure at 0.13, down 26.93% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.13, up from 0.13 in the prior quarter.
• Over the last five years, Debt Ratio for AKBA reached as high as 0.37 in Q2 2022 and fell as low as 0.13 in Q4 2025.
• Historically, Debt Ratio has averaged 0.18 across 5 years, with a median of 0.17 in 2024.
• Across the five-year window, Debt Ratio soared 133.9% in 2022 and plunged 54.8% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.19 in 2022, then retreated by 22.68% to 0.14 in 2023, then increased by 22.2% to 0.18 in 2024, then dropped by 26.93% to 0.13 in 2025, then climbed by 5.25% to 0.13 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.13 in Q1 2026, 0.13 in Q4 2025, and 0.13 in Q3 2025.